In the webinar, we will introduce how Markush Editor revolutionizes the creation of patent claims through a video lasting approximately 35 minutes. Markush claims are typically complex and labor-intensive, but by using Markush Editor, digital transformation (DX) becomes possible, reducing a task that previously took two weeks to just two days. Please join this webinar to see the effects for yourself. 【Overview】 - Introduction to Markush Editor - Presentation of specific operational images through a demo - Automatic creation of Markush structures from example structure groups - Inclusion check of example structures against Markush structures - Adjustment of Markush structures - Automatic generation of Markush claim drafts 【How to Watch】 Click on "MarkushEditor On-Demand Webinar" under "Related Links" below, download the PDF, and click the link button in the PDF to watch the webinar.

As incidents related to dangerous drugs continue to emerge as a social issue, the Ministry of Health, Labour and Welfare has introduced "comprehensive designation," which categorizes substances with similar structural components as illegal drugs. This includes strengthening regulations on the manufacture and sale of designated drugs, as well as prohibiting possession and use. Additionally, Tokyo, which has its own drug regulations, is also strengthening penalties under the "Tokyo Ordinance on the Prevention of Drug Abuse." For pharmaceutical and chemical companies that handle various chemical substances daily, it has become essential to verify the latest legal regulations concerning the chemicals they intend to handle before taking any action. However, the increasing regulatory burden raises the risk of overlooking regulatory information. The CRAIS Checker, which rapidly determines the regulatory status of chemical substances based on their structural formulas, addresses recent regulations that are difficult to manage through investigations of CAS numbers or lists of regulated substances, thereby supporting quicker and more reliable compliance responses. Furthermore, our regulatory substance check technology has been selected as a solution for regulatory drug compliance by the non-profit organization Pistoia Alliance, and we also offer a "Compliance Checker" that complies with drug regulations in North America, various European countries, and India, which is available in the global market.

ChemAxon has announced the addition of direct links to vast scientific information and other publicly available information accessible through "Google Scholar" and "Google Patents," which Google indexes, from its widely used popular chemical editor MarvinSketch (hereinafter referred to as MS). Scientists want to gain new insights based on existing knowledge when designing chemical substances and wish to avoid issues such as harmful toxicity, difficult synthesis, and patent protection. Therefore, the best way to achieve this is to quickly access relevant information while drawing new structures in a chemical editor like ChemAxon's MS. This "Google chemical search button" allows users to directly search Google Patents and Scholar from the chemical editor, developed through close collaboration between ChemAxon and Google, and is available to all customers with a license starting from release 20.16. For more detailed articles, please see the link.

Patcora Inc. (CEO: Akihiro Nakamura, Headquarters: Chiyoda, Tokyo) will launch "QuickPat," a patent specification drafting support system commercialized based on a patent specification experimental item creation support system developed by a major domestic pharmaceutical company. This system enables the reduction of the diverse work time required for creating patent specification experimental items to less than about one-third (※), contributing to the acceleration of new drug research and development. The system utilizes internal information assets such as electronic notebooks and compound/active databases to create drafts of experimental items, significantly shortening the time required for drafting patent specification experimental items. Additionally, various checking mechanisms allow for the creation of accurate and robust experimental items. Along with the sale of this system, integration services will be provided to connect the electronic lab notebooks of implementing companies and reflect their patent specification drafting policies. Patcora is focused on the chemical information systems business and aims to contribute to the acceleration of new drug research and development through highly specialized solutions. (※) Based on the experiences of existing users from surveys; results may vary by case.